Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

SABCS 2017 /
The role of axiliary node dissection in modern breast cancer surgery

5th - 9th Dec 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 09.12.17
Views: 1725

Dr Viviana Galimberti - European Institute of Oncology, Milan, Italy

Dr Viviana Galimberti speaks with ecancer at SABCS 2017 about the role of axillary node dissection in modern breast cancer surgery.

She describes 10 year follow-up results from a trial of over 900 women who were surveilled for micro metastases in sentinel nodes, who were then randomised to axillary dissection or no surgery.

Overall, Dr Galimberti describes the lack of significant difference between the arms in DFS and OS as further evidence to no longer conduct axillary node dissection for patients with micrometastatic sentinel nodes.

For more on axillary node dissection, watch our interview with Prof Tari King here.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation